Ginkgo expert Baikang Biological Group intends to list on NASDAQ
Keyword: Ginkgo, Baikang Biological, NASDAQ

Known as "the first stock of the Ginkgo industry", Baikang Biological Group Holdings Ltd (Baikang Biological) has filed a prospectus 1 (F-1/A) with the U.S. Securities and Exchange Commission (SEC) on July 30, US time, and the company intends to list on the NASDAQ market under the ticker code "BKSW." Joseph Stone Capital, LLC underwriter of the IPO. The IPO of Baikang Biological plans to issue 1.6 million to 2.4 million common shares, with a maximum offering price of no more than $6 per share, and a net offering of $6.4 million to $10.2 million.

As a provider of a variety of proprietary natural health and nutrition products specializing in ginkgo, Baikang Biological has established five core product lines, including 26 products in total including nutritional health products (including ginkgo powder drinks and various dietary supplements). It is reported that if the "beach landing" success, marking China's nutritional health food industry to a new level.

The latest article
Recommended enterprise
Back to top